Group 4D: Breast Cancer; Microbiome; Immunotherapy

Poster #P4-08-16: Modulating Gut Microbiota to enhance the efficacy of Immunotherapy in Triple Negative Breast Cancer (TNBC)

Poster #P4-11-05: Aromatase inhibitors mediate specific gut-bug interactions to shift the microbiome and decrease inflammation during adjuvant treatment in breast cancer patients